Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0598
-0.0002 (-0.39%)
At close: Dec 26, 2025
PVCT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.07 | 0.31 | 0.08 | 0.02 | 0.68 | 0.1 | Upgrade |
Cash & Short-Term Investments | 0.07 | 0.31 | 0.08 | 0.02 | 0.68 | 0.1 | Upgrade |
Cash Growth | -60.00% | 301.49% | 254.44% | -96.84% | 602.43% | -83.54% | Upgrade |
Accounts Receivable | - | - | 0 | 0 | - | - | Upgrade |
Other Receivables | - | - | - | - | 0.01 | 0 | Upgrade |
Receivables | - | - | 0 | 0 | 0.01 | 0 | Upgrade |
Prepaid Expenses | 0.11 | 0.49 | 0.34 | 0.47 | 0.33 | 0.32 | Upgrade |
Restricted Cash | - | 0.18 | 0.95 | 1.41 | 2.42 | - | Upgrade |
Other Current Assets | 0.09 | - | - | - | - | - | Upgrade |
Total Current Assets | 0.28 | 0.98 | 1.36 | 1.9 | 3.44 | 0.42 | Upgrade |
Property, Plant & Equipment | 0.14 | 0.03 | 0.08 | 0.14 | 0.07 | 0.17 | Upgrade |
Total Assets | 0.42 | 1.01 | 1.45 | 2.04 | 3.51 | 0.59 | Upgrade |
Accounts Payable | 1.18 | 1.11 | 1.68 | 2.09 | 1.29 | 0.96 | Upgrade |
Accrued Expenses | 2.97 | 2.35 | 3.39 | 2.48 | 2.02 | 6.04 | Upgrade |
Short-Term Debt | 0.11 | 0.21 | 0.28 | 0.24 | 0.24 | 0.21 | Upgrade |
Current Portion of Long-Term Debt | 2.18 | 2.95 | 2.68 | 1.83 | 1.46 | 23.42 | Upgrade |
Current Portion of Leases | 0.05 | 0.03 | 0.05 | 0.04 | 0.05 | 0.08 | Upgrade |
Current Unearned Revenue | - | 0.34 | 0.95 | 1.51 | 2.5 | - | Upgrade |
Other Current Liabilities | - | - | - | - | 0.15 | - | Upgrade |
Total Current Liabilities | 6.47 | 6.98 | 9.02 | 8.19 | 7.7 | 30.71 | Upgrade |
Long-Term Debt | 0.02 | - | - | - | - | 0.04 | Upgrade |
Long-Term Leases | 0.09 | - | 0.03 | 0.07 | - | 0.04 | Upgrade |
Total Liabilities | 6.59 | 6.98 | 9.04 | 8.27 | 7.7 | 30.8 | Upgrade |
Common Stock | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.4 | Upgrade |
Additional Paid-In Capital | 255.16 | 251.09 | 244.71 | 242.95 | 241.44 | 209.92 | Upgrade |
Retained Earnings | -261.69 | -257.42 | -252.69 | -249.59 | -246.03 | -240.49 | Upgrade |
Comprehensive Income & Other | -0.06 | -0.06 | -0.06 | -0.04 | -0.03 | -0.03 | Upgrade |
Total Common Equity | -6.17 | -5.97 | -7.62 | -6.25 | -4.21 | -30.21 | Upgrade |
Minority Interest | -0.02 | -0.01 | - | - | - | - | Upgrade |
Shareholders' Equity | -6.17 | -5.97 | -7.59 | -6.23 | -4.19 | -30.21 | Upgrade |
Total Liabilities & Equity | 0.42 | 1.01 | 1.45 | 2.04 | 3.51 | 0.59 | Upgrade |
Total Debt | 2.44 | 3.18 | 3.03 | 2.18 | 1.74 | 23.8 | Upgrade |
Net Cash (Debt) | -2.37 | -2.88 | -2.95 | -2.16 | -1.06 | -23.7 | Upgrade |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.06 | Upgrade |
Filing Date Shares Outstanding | 420.28 | 420.28 | 419.52 | 419.5 | 419.45 | 403.56 | Upgrade |
Total Common Shares Outstanding | 420.28 | 420.28 | 419.52 | 419.5 | 419.45 | 398.81 | Upgrade |
Working Capital | -6.19 | -6 | -7.65 | -6.29 | -4.26 | -30.29 | Upgrade |
Book Value Per Share | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | -0.08 | Upgrade |
Tangible Book Value | -6.17 | -5.97 | -7.62 | -6.25 | -4.21 | -30.21 | Upgrade |
Tangible Book Value Per Share | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | -0.08 | Upgrade |
Machinery | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.